Sort
16,179 grants matching “malaria”
COVID Transmission and Morbidity in Malawi (COVID-TMM)
$618,911Clarissa Valim · Boston University Medical Campus · R01 · FY2023 · AI
Breastmilk Transmission of HIV: Virology, Pharmacokinetics, and Adherence in BAN
$618,887Susan A. Fiscus · Univ Of North Carolina Chapel Hill · R56 · FY2010 · AI
Supramolecular nanofiber vaccines
$618,842Joel H Collier · University Of Chicago · R01 · FY2015 · AI
Engineering pluripotent stem cells to evade and promote immunity
$618,792Christopher Michael Sturgeon · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · EB
Natural Product Inspired Novel Antimalarials with Radical Cure Potential
$618,729Papireddy Kancharla · Portland State University · R01 · FY2025 · AI
A structured transcriptional switching network that coordinates antigenic variation by malaria parasites
$618,539Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
A structured transcriptional switching network that coordinates antigenic variation by malaria parasites
$618,539Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis
$618,537Leah Elizabeth Cowen · University Of Toronto · R01 · FY2024 · AI
Multi-scale model of microbial phenotype modulation by mucins
$618,287Jason Papin · University Of Virginia · R01 · FY2021 · AI
Microbiome Affects Risk of Growth in HIV-exposed but Unifected Infants-Nigeria
$618,275Manhattan E Charurat · University Of Maryland Baltimore · R01 · FY2016 · DE
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
$618,210James Walter Kazura · Case Western Reserve University · R01 · FY2015 · AI
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug
$618,129Stephen Lev Hoffman · Sanaria, Inc. · U01 · FY2013 · AI
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies
$617,996Philip Jon Rosenthal · University Of California, San Francisco · R56 · FY2008 · AI
Innate lymphocyte function in malaria
$617,879Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Behavior-Modifying Compounds for Disease Vector Control
$617,822Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2004 · AI
Administrative Core
$617,791Peter C Agre · Johns Hopkins University · U19 · FY2012 · AI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis
$617,457Leah Elizabeth Cowen · University Of Toronto · R01 · FY2025 · AI
Predicting tuberculosis outcomes using genotypic and biomarker signatures
$617,451Gillian L Beamer · Tufts University Boston · R01 · FY2019 · HL
Sustainable Control of Aedes aegypti and epidemic dengue
$617,343Lars Eisen · Colorado State University · U01 · FY2012 · AI
Innate lymphocyte function in malaria
$617,288Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Molecular mechanisms of schizogony in malaria parasites
$617,178Jeffrey D Dvorin · Boston Children'S Hospital · R01 · FY2019 · AI
Sustainable Control of Aedes aegypti and epidemic dengue
$617,169Barry J Beaty · Colorado State University · U01 · FY2011 · AI
Exploring the roles of acquired immunity and functional constraint in sculpting malaria antigenic diversity in a longitudinal cohort
$617,080Daniel E Neafsey · Harvard School Of Public Health · R01 · FY2020 · AI
ICBG: "Training, Conservation and Drug Discovery using Panamanian Microorganisms
$616,936William H Gerwick · Smithsonian Institution · U01 · FY2011 · TW
ICBG: "Training, Conservation and Drug Discovery using Panamanian Microorganisms
$616,936William H Gerwick · Smithsonian Institution · U01 · FY2012 · TW